ARCHIVES

Drugs and Targets: Cyramza approved in metastatic stomach cancer

This article is from The Cancer Letter archive.

Vol. 40 No. 42 | November 7, 2014

Download PDF Visit The Full Archive

Related Articles

No Benefit For Radiation For Early Stage Disease Spread To Only One Node

March 26, 2010

Merck Serono Cancels Tecemotide Program In NSCLC, Including Two Phase III Trials

September 26, 2014

In Brief: Clinical Education Program to Be Phased Out; Ken Endicott Retires From Grupenhoff Firm

January 31, 1986

NCI-Approved Trials Listed

April 28, 2006

Moddelmog Steps Down At Komen For the Cure

November 20, 2009

In Brief: NCI Figure Left unchanged By Carter; Pay Raise Puts further Squeeze On Institute Budget

March 4, 1977